← Back to Clinical Trials
Recruiting NCT01163578
Biomarkers in Transplant Recipients to Improve Outcomes
Trial Parameters
Condition Solid Organ Transplantation
Sponsor University of Pittsburgh
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,200
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2005-03
Completion 2030-03
All Conditions
Brief Summary
The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.
Eligibility Criteria
Inclusion Criteria: * Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center. * All Ages * Subject or parents are able to read and understand the informed consent Exclusion Criteria: * Subjects and/or their parents who are unable to read and understand informed consent.
Related Trials
NCT06774339
Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term O
View Trial →
NCT07291258
Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines
View Trial →
NCT01163578
Biomarkers in Transplant Recipients to Improve Outcomes
View Trial →